FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced it has received a final Medicare coverage determination for its ...
Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina's growing research and clinical ...
TUCSON, Ariz., July 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced three of ...
Together with the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s ...
The combination of convenient at-home, finger-prick blood collection and the ultra-sensitive DriverMap TM EXP Human Genome-Wide Profiling Kit greatly simplifies the discovery of clinically relevant ...
MOUNTAIN VIEW, Calif., May 6, 2025 /PRNewswire/ -- Cellecta, Inc. today announced the launch of the DriverMap™ EXP Human Genome-Wide 19K Dried Blood Microsample Profiling kit, a targeted RNA ...
PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results